476 related articles for article (PubMed ID: 6333404)
21. [Immunological aspects of pulse therapy in systemic lupus erythematosus].
Nasonov EL; Solov'ev SK; Ivanova MM; Timofeeva EB; Lekakh IV
Ter Arkh; 1986; 58(7):49-54. PubMed ID: 3764741
[TBL] [Abstract][Full Text] [Related]
22. [Advances in nephrology. Lupus nephritis].
Siciński A
Pol Arch Med Wewn; 1982 Mar; 67(3):125-31. PubMed ID: 7050938
[No Abstract] [Full Text] [Related]
23. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
[TBL] [Abstract][Full Text] [Related]
24. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
26. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.
Winfield JB; Faiferman I; Koffler D
J Clin Invest; 1977 Jan; 59(1):90-6. PubMed ID: 299748
[TBL] [Abstract][Full Text] [Related]
27. Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.
Clark WF; Linton AL; Cordy PE; Keown PE; Lohmann RC; Lindsay RM
Can Med Assoc J; 1978 Jun; 118(11):1391-5. PubMed ID: 350367
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating immune complexes in patients with glomerulonephritis.
Szewczyk Z; Falkiewicz K; Kopeć W
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):577-81. PubMed ID: 373683
[TBL] [Abstract][Full Text] [Related]
29. [Immunopathology of the kidney in disseminated lupus erythematosus].
Morel-Maroger L; Méry JP
Pathol Biol (Paris); 1975 Jun; 23(6):492-3. PubMed ID: 1105354
[No Abstract] [Full Text] [Related]
30. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
31. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
Harkiss GD; Hazleman BL; Brown DL
J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
[TBL] [Abstract][Full Text] [Related]
32. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between immunopathologic renal lesions and circulating immune complexes in generalized lupus erythematosus in children].
Vázquez-Escobosa C; Gortazar-Hijar P; González-Mendoza A
Bol Med Hosp Infant Mex; 1984 Jul; 41(7):363-8. PubMed ID: 6236832
[No Abstract] [Full Text] [Related]
34. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
Cavallo T; Graves K; Granholm NA
Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840
[TBL] [Abstract][Full Text] [Related]
35. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
36. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
[TBL] [Abstract][Full Text] [Related]
37. Complement and sepsis.
Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
[TBL] [Abstract][Full Text] [Related]
38. [Circulating immune complexes and C3 in patients with systemic lupus erythematosus. The relationship between clinical manifestations and nephropathy (author's transl)].
Rodríguez-Valverde V; Peña Sagredo JL; Orte Martínez J; Novo Fernández MJ; Sánchez Andrada S; Sampedro Alvarez J
Med Clin (Barc); 1982 May; 78(9):353-7. PubMed ID: 6808263
[No Abstract] [Full Text] [Related]
39. [Significance of the study of complement in glomerulonephritis. Research on some serum complement fractions and their detection in renal biopsies with the use of microscopy and immunofluorescence].
Martini PF; Camussi G; Segoloni G; Rotunno M; Triolo G; Mangiarotti G; Messina M; Caramello E
Recenti Prog Med; 1978 Mar; 64(3):354-73. PubMed ID: 351753
[No Abstract] [Full Text] [Related]
40. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
